Wednesday, 14 October 2026 Updated 13 min ago
The News Engine
Latest
Business United States

Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits

Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.

CNBC reports: Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.

This business story centres on the United States. Names and organisations mentioned in the coverage include GLP-, Novo's Ozempic and Lilly's Mounjaro.

Why it matters

Moves like this are watched by investors, employers and consumers because of their potential effect on markets and the wider economy.

Key details

Location
United States · Americas
Reported by
CNBC
First reported
Key names
GLP-, Novo's Ozempic, Lilly's Mounjaro, Type
Section
Business

Sources

This is an independent summary. Read the full, original reporting from the publisher:

Read the full story at CNBC

Spotted an error? Request a correction · How this summary was produced

Related Stories